ATE155344T1 - Verfahren zur sicherstellung eines angemessenen intrazellulären glutathionspiegels im gewebe - Google Patents

Verfahren zur sicherstellung eines angemessenen intrazellulären glutathionspiegels im gewebe

Info

Publication number
ATE155344T1
ATE155344T1 AT92101515T AT92101515T ATE155344T1 AT E155344 T1 ATE155344 T1 AT E155344T1 AT 92101515 T AT92101515 T AT 92101515T AT 92101515 T AT92101515 T AT 92101515T AT E155344 T1 ATE155344 T1 AT E155344T1
Authority
AT
Austria
Prior art keywords
tissue
ensure adequate
intracellular glutathione
glutathione levels
adequate intracellular
Prior art date
Application number
AT92101515T
Other languages
English (en)
Inventor
David A Mark
W Bruce Rowe
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE155344T1 publication Critical patent/ATE155344T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT92101515T 1991-02-04 1992-01-30 Verfahren zur sicherstellung eines angemessenen intrazellulären glutathionspiegels im gewebe ATE155344T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65022291A 1991-02-04 1991-02-04

Publications (1)

Publication Number Publication Date
ATE155344T1 true ATE155344T1 (de) 1997-08-15

Family

ID=24608000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92101515T ATE155344T1 (de) 1991-02-04 1992-01-30 Verfahren zur sicherstellung eines angemessenen intrazellulären glutathionspiegels im gewebe

Country Status (9)

Country Link
EP (1) EP0502313B1 (de)
JP (1) JPH04327537A (de)
AT (1) ATE155344T1 (de)
AU (1) AU652988B2 (de)
CA (1) CA2060560C (de)
DE (1) DE69220821T2 (de)
DK (1) DK0502313T3 (de)
ES (1) ES2106096T3 (de)
GR (1) GR3024638T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
AU5040493A (en) * 1992-11-30 1994-06-09 Transcend Therapeutics, Inc Method for treating systemic inflammatory response syndrome
AU6060694A (en) * 1993-05-10 1994-11-17 Transcend Therapeutics, Inc Method for treating acquired immune deficiency syndrome
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US5821217A (en) * 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
RU2089179C1 (ru) * 1995-12-14 1997-09-10 Закрытое акционерное общество "ВАМ" Стимулятор эндогенной продукции цитокинов и гепопоэтических факторов и способ его использования
US6251857B1 (en) 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
US20070142267A1 (en) 1998-11-23 2007-06-21 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
RU2144374C1 (ru) 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
EP1663256A1 (de) * 2003-09-19 2006-06-07 N.V. Nutricia Kohlehydratzusammensetzung und ihre verwendung zur herstellung eines medikaments zur behandlung oder prävention von lungenentzündung oder akutem atemnotsyndrom
JP2006219458A (ja) * 2005-02-14 2006-08-24 Meiji Milk Prod Co Ltd 虚血性腸疾患抑制剤
JP5784869B2 (ja) * 2008-04-28 2015-09-24 太陽化学株式会社 抗炎症剤
CN101880702B (zh) * 2009-05-07 2012-12-12 成都自豪药业有限公司 一种采用产朊假丝酵母发酵生产谷胱甘肽的方法
EP3328410B1 (de) * 2015-07-30 2020-09-23 Merck Patent GmbH Verfahren zur erhöhung des glutathion levels in zellen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
FR2544613B1 (fr) * 1983-04-20 1985-10-25 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique, en reanimation et en therapeutique, renfermant une fraction proteique a base de trois types de minipeptides
EP0357776A4 (en) * 1987-05-14 1991-01-30 Terumo Kabushiki Kaisha Egg white hydrolyzate
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement

Also Published As

Publication number Publication date
AU1065992A (en) 1992-08-06
GR3024638T3 (en) 1997-12-31
EP0502313A2 (de) 1992-09-09
DE69220821D1 (de) 1997-08-21
DK0502313T3 (da) 1998-02-02
CA2060560A1 (en) 1992-08-04
ES2106096T3 (es) 1997-11-01
JPH04327537A (ja) 1992-11-17
EP0502313A3 (en) 1993-05-12
EP0502313B1 (de) 1997-07-16
AU652988B2 (en) 1994-09-15
DE69220821T2 (de) 1997-11-20
CA2060560C (en) 2002-07-23

Similar Documents

Publication Publication Date Title
ATE155344T1 (de) Verfahren zur sicherstellung eines angemessenen intrazellulären glutathionspiegels im gewebe
ATE196428T1 (de) Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
ATE221377T1 (de) Verfahren zur reduzierung der körperfettanteils bei tieren mit der verabreichungvon konjugiergter linolsäure
KR880700668A (ko) 특정 생체조직 부위로의 전달을 위한 아미노산 킬레이트의 조성물
DE3851203D1 (de) Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69429297T2 (de) Zusammensetzung zur Behandlung von Patienten mit Lebererkrankungen
DK0725648T3 (da) Leverspecifikke farmaceutiske aktivstoffer
ATE163768T1 (de) Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
NL300106I1 (nl) N-terminaal chemisch gemodificeerde eiwitpreparaten en werkwijzen.
DE69620291T2 (de) Nahrungszusammensetzungen in verschiedenen Formen
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
KR910009246A (ko) 폴리펩타이드를 함유하는 피하투여용 또는 근육내 투여용 약제
DE69719931T2 (de) Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
SE8802569L (sv) Foerbaettringar vid eller avseende somatosstatiner
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
DE69227042T2 (de) Verfahren und zusammensetzungen zur verminderung von blutverlust
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
ES2092969A1 (es) Surfactante pulmonar natural de origen porcino.
DE69004051D1 (de) Verwendung eines Polypeptides mit Gammainterferon-Aktivität zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von primitivem Pleura-Krebs.
ATE158719T1 (de) Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung
SE9302006D0 (sv) Protein formulation
NZ243860A (en) Increasing glutathione levels in human and animal organs using whey protein concentrate
ES2070791A1 (es) Composicion cosmetica para el cuidado de la piel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee